by Becky Kelly | Sep 24, 2024 | Blog
BLOG A Critical Moment for Telehealth Prescribing: DEA’s Proposed Rule Update As the DEA’s proposed rule on telehealth prescribing of controlled substances moves through the final stages of review, stakeholders across healthcare, telemedicine, and patient advocacy are... 
by Becky Kelly | Sep 3, 2024 | Blog
BLOG Understanding EPCS Certification Electronic Prescribing of Controlled Substances (EPCS) certification is a crucial development in the healthcare industry, designed to facilitate the secure and legal electronic transmission of prescriptions for controlled... 
by Becky Kelly | Aug 23, 2024 | Blog
BLOG Enhancing Patient Safety with EPCS: A High-Level Overview Effective January 1st of 2023, the Centers for Medicare and Medicaid Services (CMS) mandated the use of electronic prescribing of controlled substances (EPCS). This mandate means all schedule II, III, IV,... 
by Becky Kelly | Aug 19, 2024 | Blog
BLOG Adapting to Future Needs in E-Prescribing: How DoseSpot Leads the Way In recent years, healthcare provider technology has seen significant advancements in e-prescribing, which aim to streamline processes, improve patient outcomes, and ensure regulatory... 
by Becky Kelly | Jul 26, 2024 | Blog
BLOG How DoseSpot Simplifies the E-Prescribing Process for Dental Practices In today’s competitive dental industry, efficiency and superior patient care go hand in hand with thriving practices. As technology continues to evolve, dental practices are also continually... 
by Becky Kelly | Jul 9, 2024 | Blog
BLOG What You Need To Know: DEA Proposed Rule Regarding Telehealth Prescribing of Controlled Substances with the White House As of June 2024, a DEA proposed rule regarding telehealth prescribing of controlled substances has reached the White House for review. This... 
